logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Fredun Pharma Share Price

Fredun Pharmaceuticals Ltd.

1,695

23.20(1.39%)
1st Apr 2026 | 12:26 PM
NSE :
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Fredun Pharma Performance

Price Movement

N/A

₹1667.20

₹1750.00

Today's LowToday's High

1 Year Performance

Data is not available

Markets Today

High₹1,750.00
Low₹1,667.20
Open at₹1,667.20
Prev Close₹1,671.80
Volumes3.12 K
Avg Price₹1,700.51
Lower Circuit₹1,337.45
Upper Circuit₹2,006.15

Historical Performance

3M High₹1,944.00
3M Low₹1,362.15
1 Yr High₹1,999.00
1 Yr Low₹635.05
3 Yr High₹1,999.00
3 Yr Low₹635.00
5 Yr High₹1,999.00
5 Yr Low₹351.20

Fredun Pharma Fundamentals

Market Cap
Above industry Median
795.90 Cr.
PE Ratio (TTM)
Above industry Median
23.40
Dividend Yield
Low in industry
0
Net Profit TTM
81.1% incr over last year
34.05
Net Profit Growth
81.1% incr over last year
34.05
PEG Ratio
Above industry Median
0.30
ROE
14.4% incr over last year
14.71
Operating Revenue TTM
588.35
Operating Revenue Growth
45.5% incr over last year
Book Value
Above industry Median
4.70
MFI
MFI is mid-range
55.58
RSI
RSI is mid-range
52.67
EPS (TTM)
-
Debt to Equity
-
Face Value
10
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
26.34
Net Profit Qtr.
10.48
Operating Revenue Qtr.
160.92
PB Ratio
4.70

Fredun Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue159.93143.59119.40165.44101.84
Operating Expense134.59122.96102.86149.9789.47
Operating Profit25.3420.6316.5415.4712.37
Depreciation1.781.601.421.251.09
Interest10.557.736.538.155
Tax3.523.272.270.971.80
Net Profit10.489.736.777.075.33

Fredun Pharma Technicals

Fredun Pharmaceuticals Ltd. EMA & SMA

1695.00

1.25 (0.07%)

Bullish Moving Average

15

Bearish Moving Average

1

Day EMA5 ₹1680.5
Day EMA10 ₹1668.2
Day EMA12 ₹1664.7
Day EMA20 ₹1656.7
Day EMA26 ₹1653.3
Day EMA50 ₹1643.6
Day EMA100 ₹1591.9
Day EMA200 ₹1430

Fredun Pharma Support and Resistance

Resistance

First Resistance₹1690.53
Second Resistance₹1709.27
Third Resistance₹1719.53

Support

First Support₹1661.53
Second Support₹1651.27
Third Support₹1632.53

Technical Indicators

Day RSI52.67
Day MFI55.58
Day ADX19.19
Day Commodity Channel Index63.40
William-58.30
Day MACD11.33
Day MACD Signal Line4.13
Day ATR96.20
Day ROC12529.42
Day ROC211.52

Fredun Pharma Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter48.948.948.948.948.943.1
FII000000.5
DII1.61.61.61.61.63.4
Public49.549.549.549.549.553

Fredun Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day3.67 K6.97 K52.68%
Week5.35 K8.43 K63.49%
1 Month4.53 K8.68 K52.16%
6 Month8.08 K11.68 K69.20%

Fredun Pharma SWOT Analysis

Strengths24
Weakness3
Opportunity1
Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Fredun Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
23 Sep, 20250.7FINAL23 Sep, 2025Equity Share
23 Sep, 20240.7FINAL23 Sep, 2024Equity Share
22 Sep, 20230.7FINAL22 Sep, 2023Equity Share
13 Sep, 20220.7FINAL15 Sep, 2022Equity Share
16 Sep, 20210.7FINALEquity Share
18 Sep, 20200.66FINAL21 Sep, 2020Equity Share
16 Sep, 20190.65FINALEquity Share
18 Sep, 20180.6FINALEquity Share
20 Sep, 20170.6FINALEquity Share
11 Apr, 20160.6INTERIMEquity Share

Fredun Pharma Stock Comparison

Financials
Price (₹)₹217₹36.87₹5.54₹99.90₹345.05₹102.31
% Change4.35%1.99%4.92%7.48%-1.17%2.50%
Revenue TTM (₹ Cr)-₹0.54₹83.60--₹282.74
Net Profit TTM (₹ Cr)-₹-0.24₹-34.95--₹15.30
PE TTM60.10-91.90-1.3012.3077.3025.30
1 Year Return703.33428-27.38-20.79
ROCE---5.63---

FAQ's on FREDUN

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy